Inicio>>Cholesterol‑Undecanoate‑Glucose Conjugate

Cholesterol‑Undecanoate‑Glucose Conjugate

Catalog No.GC90953

Un conjugado de lípidos basado en glucosa.

Products are for research use only. Not for human use. We do not sell to patients.

Cholesterol‑Undecanoate‑Glucose Conjugate Chemical Structure

Tamaño Precio Disponibilidad Cantidad
1 mg
50,00 $
Disponible
5 mg
202,00 $
Disponible
10 mg
303,00 $
Disponible

Tel:(909) 407-4943 Email: sales@glpbio.com


Reseñas de cliente

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents

Cholesterol-undecanoate-glucose conjugate is a glucose-based lipid conjugate that has been used in the generation of brain-targeted liposomes.1 It forms a stable, ordered bilayer with phospholipids with the glucose moiety facing outward for the purpose of being recognized by glucose transporter 1 (GLUT1) on the blood-brain barrier. Intravenous and intranasal administration of fluorescently labeled liposomes containing cholesterol-undecanoate-glucose conjugate and encapsulating the antimalarial artesunate and the metlated pyrazine ligustrazine induces increased brain fluorescence intensity and a reduced infection rate in a mouse model of P. falciparum-induced cerebral malaria when compared with fluorescently labeled non-cholesterol-undecanoate-glucose conjugate-containing liposomes encapsulating artesunate and ligustrazine.

Reseñas

Review for Cholesterol‑Undecanoate‑Glucose Conjugate

Average Rating: 5 ★★★★★ (Based on Reviews and 30 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Cholesterol‑Undecanoate‑Glucose Conjugate

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.